Combined procedure for PEXG and cataract

Article

Combined phacoemulsification and viscocanalostomy achieves excellent intraocular pressure (IOP) control and improves visual acuity (VA) in patients with co-existing cataract and pseudoexfoliation glaucoma (PEXG).

Combined phacoemulsification and viscocanalostomy achieves excellent intraocular pressure (IOP) control and improves visual acuity (VA) in patients with co-existing cataract and pseudoexfoliation glaucoma (PEXG), according to Mohammed Awadalla and colleagues from Saudi Arabia.

A prospective, non-comparative study of 30 consecutive eyes with uncontrolled PEXG associated with cataract was conducted. Each subject received the combined phacoemulsification and viscocanalostomy procedure. Postoperative follow-up ranged from between 12 and 24 months.

At the final follow-up, IOP was reduced by more 30% with only five eyes (16.6%) requiring a single anti-glaucoma medication to achieve target IOP. The mean preoperative best spectacle corrected visual acuity (BSCVA) was 0.16, whilst mean postoperative uncorrected vision and BSCVA were 0.5 and 0.7, respectively. Complication rates were low and did not affect the surgical outcome.

The results of this study reveal that combined phacoemulsification and viscocanalostomy can achieve excellent results in both IOP control and visual acuity.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.